How ‘Forever Chemicals’ May Sabotage the Gut-Liver Axis, Lab Study Finds

If you have ever wondered whether the "forever chemicals" in your water bottle or takeout wrapper could be connected to sluggish digestion, unexplained bloating, or a liver panel that keeps coming back a little off, a new pilot study offers one of the first mechanistic clues tying the two together. Researchers at Örebro University in Sweden built a lab model that traces per- and polyfluoroalkyl substances (PFAS, a family of manufactured chemicals used in nonstick cookware, waterproof fabrics, and food packaging that resist breaking down in the environment) from the gut, through microbial byproducts, into human liver cells. What they found is that the chemicals may not just be toxic to the liver directly. They may be reprogramming gut bacteria in ways that then disturb liver metabolism on their own.

Key takeaways:

• In a lab model combining human stool, liver cells and mice, exposing gut bacteria to a mixture of five PFAS chemicals altered the byproducts (metabolites) those bacteria produce.
• Human liver cells exposed to those PFAS-altered gut byproducts showed changes in fat transport and bile acid processing that were not seen with direct PFAS exposure alone, pointing to gut bacteria as an active go-between.
• This is an early-stage pilot study in cells, mouse feces, and an artificial gut model, not a study of PFAS exposure and health outcomes in living people, so the mechanism is plausible but unconfirmed in humans.

PFAS Exposure Alters Gut Microbial Metabolites, New Study Shows

Researchers found that when human gut bacteria were exposed to a mixture of five common PFAS chemicals, the metabolites (small molecules produced when bacteria break down food and other compounds) those bacteria released changed measurably compared with unexposed bacteria. The team, led by Andi Alijagic, Victor Castro-Alves and Tuulia Hyötyläinen and published in Environment International, used stool samples from nine healthy donors (ranging in age from 24 to 38) to simulate human colon fermentation in the lab, then dosed the resulting bacterial communities with a mixture of five PFAS compounds, PFOS, PFOA, PFHxS, PFNA and PFDA, at concentrations chosen to reflect real-world human exposure levels. The PFAS exposure shifted pathways tied to fatty acid, amino acid, vitamin and mitochondrial metabolism in the bacterial byproducts within hours.

Why the Gut-Liver Connection Matters for Metabolic Health

The reason this matters goes beyond the gut itself. The researchers then took the purified extracts from those PFAS-exposed bacterial cultures and applied them to HepaRG cells, a widely used human liver cell line, to see how the liver would respond to gut bacteria's chemically altered byproducts rather than to the PFAS itself. The liver cells exposed to PFAS-altered gut extracts showed decreased acylcarnitines and increased L-carnitine, changes consistent with disrupted fatty acid transport and mitochondrial beta-oxidation (the process cells use to break down fat for energy). That pattern is relevant to anyone tracking their risk for metabolic dysfunction-associated steatotic liver disease (MASLD, the newer name for what used to be called fatty liver disease), since impaired fat-burning machinery in liver cells is one of the pathways thought to drive fat accumulation in the liver.

A Study Design Built to Separate PFAS from Its Gut-Altered Byproducts

The strength of this pilot study is a deliberately layered design meant to rule out simpler explanations. Beyond the human-donor fermentation and hepatocyte exposures, the researchers ran a parallel PFOA-dosed mouse experiment (16 mice total, split evenly between males and females and between control and PFOA-exposed groups over 28 days) to see whether the same metabolic pathways showed up in a living animal. They did, particularly in fatty acid, bile acid and steroid hormone metabolism, which the authors say supports the biological relevance of the lab-dish findings. Critically, the team also ran a control arm in which unexposed gut extracts were spiked with the same amount of PFAS just before touching the liver cells, rather than being altered by PFAS beforehand. Liver cells responded differently to microbiota-altered extracts than to PFAS-spiked ones, which is what let the researchers argue the effect comes from PFAS changing what gut bacteria produce, not simply PFAS carrying over into the liver-cell dish.

What This Could Mean If You're Watching Your Liver or Gut Health

For someone already researching a suspected gut-liver connection, whether prompted by a fatty liver diagnosis, unexplained metabolic symptoms, or general concern about environmental chemical exposure, this study is not a reason to change any specific behavior, but it is a reason to take the gut microbiome seriously as a possible middleman in chemical exposure risk. The researchers also found that PFAS-altered gut extracts shifted three bile acids (cholic acid, taurochenodeoxycholic acid and taurodeoxycholic acid), along with steroid metabolites, inosine and sialic acid derivatives, in liver cells. Bile acids regulate fat digestion and signal to the liver and gut, so a bacteria-driven shift in bile acid levels is a plausible link between PFAS exposure and broader metabolic disruption, though it has not been shown to cause disease in this study. This is not a basis for a specific detox protocol or supplement; no intervention was tested here, and none should be inferred from it.

Limitations the Researchers Are Upfront About

The authors are explicit that this is a pilot study, and they flag several limits worth taking seriously. The human side of the experiment relied on stool from just nine donors, small enough that the authors call the findings preliminary and say they warrant validation in larger studies. No PFAS-exposed human being was tracked in this study at any point; the donors' stool served only as inoculum for an artificial fermentation system, and the actual health effects were measured in liver cells and mice, not people. The researchers also note that removing endotoxins from the fermentation extracts before applying them to liver cells, a necessary step to keep the cells alive, may have altered the extract's composition, so the liver-cell results reflect that purified fraction rather than everything gut bacteria would produce in a real gut. The authors reported no competing financial interests, and the work was funded entirely by public and nonprofit sources, including the Swedish Research Council, Formas, the Novo Nordisk Foundation, Horizon Europe and the Swedish Knowledge Foundation, with no industry funding disclosed.

What Comes Next for PFAS and Gut-Liver Research

The authors frame this as a foundation for larger studies that could eventually measure these same metabolic pathways, decreased acylcarnitines, shifted bile acids, altered steroid metabolism, directly in people with known PFAS exposure, rather than in lab models built from their stool. They suggest that if these pathway-level signals can be validated at scale, they could eventually serve as early biomarkers for PFAS-related metabolic harm, feeding into human health risk assessments for PFAS regulation. That work has not been done yet.

Common Questions

Does this mean PFAS chemicals cause fatty liver disease in humans? Not on its own. This study shows a plausible biological pathway, PFAS altering gut bacteria byproducts that then disrupt liver fat metabolism in cells and mice, but it does not measure PFAS exposure or liver disease in living people.

What PFAS chemicals were tested? The researchers used a mixture of five: PFOS, PFOA, PFHxS, PFNA and PFDA, all common PFAS compounds found in everyday exposure, dosed at levels meant to reflect typical human exposure.

Should I take a supplement or detox product because of this study? No. The study did not test any intervention, supplement or detox strategy, and nothing here establishes one as effective for reducing PFAS-related liver risk.

Why did the researchers use mice and lab-grown liver cells instead of studying people directly? Cell and animal models let researchers isolate a specific mechanism, whether gut bacteria byproducts affect liver cells differently than PFAS itself, in a way that is not currently possible to test directly and ethically in humans with controlled PFAS exposure.

References

Andi Alijagic, Victor Castro-Alves, Tim Orin Orešič, et al. (2026). PFAS exposure alters gut microbiota metabolites associated with hepatic metabolism: a pilot study. Environment International. https://doi.org/10.1016/j.envint.2026.110463